乙肝肝硬化失代偿期并发肝功能衰竭患者血清Autotaxin、Copeptin、LBP与预后的关系研究  

Study on the relationship between serum Autotaxin,Copeptin,LBP and prognosis in patients with hepatitis B virus-related decompensated cirrhosis complicated with liver failure

作　　者：张帆[1] 毛屏[2] 张晨[1] 金星[1] 李丹[1] ZHANG Fan;MAO Ping;ZHANG Chen;JIN Xing;LI Dan(Department of Gastroenterology,The First Hospital of China Medical University,Liaoning,Shenyang 110000,China;Hepatobiliary Surgery,Liaoning Provincial People′s Hospital,Liaoning,Shenyang 110000,China)

机构地区：[1]中国医科大学附属第一医院消化内科,110000 [2]辽宁省人民医院肝胆外科,110000

出　　处：《现代消化及介入诊疗》2024年第5期534-538,共5页Modern Interventional Diagnosis and Treatment in Gastroenterology

基　　金：辽宁省自然科学基金计划项目(2022-MS-076)。

摘　　要：目的探讨乙肝肝硬化失代偿期(HBV-DC)并发肝功能衰竭(LF)患者血清自分泌运动因子(Autotaxin)、和肽素(Copeptin)、内毒素结合蛋白(LBP)与预后的关系。方法选取2018年2月至2023年8月我院收治的143例HBV-DC并发LF患者为研究对象,随访90 d,根据预后情况分组为死亡组(55例)与存活组(88例),比较两组血清Autotaxin、Copeptin、LBP水平。收集HBV-DC并发LF患者的临床资料,采用单因素和多因素Logistic回归模型分析HBV-DC并发LF患者预后的影响因素。采用受试者工作特征(ROC)曲线分析血清Autotaxin、Copeptin、LBP单独或联合预测HBV-DC并发LF患者预后的临床价值。结果143例HBV-DC并发LF患者随访90 d时,有55例死亡,88例存活,死亡率38.46%。与存活组比较,死亡组血清Autotaxin、Copeptin、LBP水平明显增加(P<0.05)。与存活组比较,死亡组住院时间≥14 d比例、并发腹水比例、并发肝性脑病比例、谷丙转氨酶、总胆红素、终末期肝病模型(MELD)评分显著升高(P<0.05),白蛋白显著降低(P<0.05),年龄、性别、合并糖尿病、合并高血压、血肌酐、血小板计数、纤维蛋白原无显著性差异(P>0.05)。总胆红素升高、并发肝性脑病、MELD评分升高以及血清Autotaxin、Copeptin、LBP水平升高均为HBV-DC并发LF患者预后不良的危险因素(P<0.05)。ROC曲线结果显示,血清Autotaxin、LBP、Copeptin标联合检测预测HBV-DC并发LF患者预后不良的曲线下面积(AUC)、灵敏度、特异度分别为0.930、85.45%、88.64%,显著优于单项指标检测预测的效能。结论血清Autotaxin、Copeptin、LBP高表达与HBV-DC并发LF患者短期死亡发生风险有关,且联合检测对HBV-DC并发LF患者短期死亡的发生具有较高的临床预测价值。Objective To investigate the relationship between serum autotaxin,copeptin,lipopolysaccharide binding protein(LBP)and prognosis in patients with hepatitis B virus-related decompensated cirrhosis(HBV-DC)complicated with liver failure(LF).Methods 143 patients with HBV-DC complicated with LF who admitted to our hospital from February 2018 to August 2023 were selected as the research objects.Patients were followed up for 90 d,patients were divided into death group(55 cases)and survival group(88 cases)according to the prognosis,the levels of serum Autotaxin,Copeptin and LBP were compared between two groups.The clinical data of patients with HBV-DC complicated with liver failure were collected,the prognostic factors of HBV-DC complicated with LF patients were analyzed by univariate and multivariate Logistic regression models.The clinical value of serum Autotaxin,Copeptin and LBP alone or in combination in predicting the prognosis of patients with HBV-DC complicated with LF were analyzed by receiver operating characteristic(ROC)curve.Results 143 patients with HBV-DC complicated with LF 90 d follow-up,55 died,and 88 survived,with a mortality rate of 38.46%.Compared with survival group,the serum levels of Autotaxin,Copeptin and LBP in death group were significantly increased(P<0.05).Compared with survival group,the proportion of hospitalization time≥14 d,the proportion of ascites,the proportion of hepatic encephalopathy,alanine aminotransferase,total bilirubin and model for end-stage liver disease(MELD)score in death group were significantly increased(P<0.05),and albumin was significantly decreased(P<0.05),there was no significant difference in age,gender,diabetes mellitus,hypertension,serum creatinine,platelet count and fibrinogen(P>0.05).Elevated total bilirubin,concurrent hepatic encephalopathy,elevated MELD score,and elevated serum Autotaxin,Copeptin,and LBP levels were risk factors for poor prognosis in patients with HBV-DC complicated with LF(P<0.05).ROC curve results showed that,the area under the curve(AUC),sens

关 键 词：乙肝肝硬化失代偿期 肝功能衰竭 自分泌运动因子 和肽素 内毒素结合蛋白 预后 预测价值 

分 类 号：R575[医药卫生—消化系统]